Inhibrx Biosciences, Inc. ($INBX)
Total Shares
27,500
Total Value
$2,932,016.56
Avg P&L
-16.8%
Timeframe
0 days
Participants
| Name | Title | Security | Derivative | Filing Date | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 5,895 | $99.29 | $585,342.85 | 711,443 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 6,605 | $100.64 | $664,719.27 | 718,048 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 9,681 | $112.28 | $1,087,001.07 | 730,548 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 1,100 | $107.12 | $117,836.29 | 719,148 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 500 | $108.23 | $54,117.50 | 719,648 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 1,219 | $111.88 | $136,382.33 | 720,867 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 8, 2026 | Sep 8, 2026 | P | 2,500 | $114.65 | $286,617.25 | 227,064 | Indirect | By the Forsyth Family Trust Dated July 20, 2001 | View Details |